Description: Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company. The Cardiac and Vascular Company segment offers angiographic guidewires, angiographic catheters, introducer sheaths, vascular closure devices, PTCA balloon catheters, coronary stents, self-expanding peripheral stents, intravascular ultrasound systems, imaging catheters, and others; coils, stents, and intrasaccular devices for treating cerebral aneurysm; embolization systems, aspiration catheters, and clot retrievers for treating ischemic stroke and others; oxygenators, cardio-pulmonary bypass systems, and others; and artificial vascular and stent grafts. The Medical Care Solutions Company segment provides syringes, infusion pumps, syringe pumps, infusion lines, I.V. solutions, peritoneal dialysis fluids, pain management and nutritious food products, adhesion barriers, and others; blood glucose monitoring systems, disposable needles for pen-injector, insulin patch pumps, blood pressure monitors, digital thermometers, and others; and contract manufacturing of prefilled syringes, devices to pharmaceutical companies for use in drug kits, such as prefillable syringes, needles for pharmaceutical packaging business, and others. The Blood and Cell Technologies Company segment offers blood bags, component collection systems, automated blood processing systems, pathogen reduction systems, centrifugal apheresis systems, cell expansion systems, and others. The company was formerly known as Sekisen Ken-onki Corporation and changed its name to Terumo Corporation in October 1974. Terumo Corporation was incorporated in 1921 and is headquartered in Tokyo, Japan.
Home Page: www.terumo.com
2-44-1, Hatagaya
Tokyo,
151-0072
Japan
Phone:
81 3 3374 8111
Officers
| Name | Title |
|---|---|
| Mr. Toshiaki Takagi | Chairman of the Board & Group Managing Executive Officer |
| Mr. Hikaru Samejima | Representative Director, President & CEO |
| Jin Hagimoto | CFO, CIO, GM of CFO Office, Controller & Treasury Tax Dept., J-SOX Office, IT Planning Dept. & GBS |
| Shinji Omori | CTO, GM of DX Promotion Dept. R&D Division and Executive Officer |
| Ms. Miho Mizuguchi | Executive Officer, Chief Legal Officer and GM of CLO Office, Legal & Compliance Department |
| Tomoko Adachi | Chief Human Resources Officer & Group Executive Officer |
| Mr. Kazunori Hirose | Director & Group Managing Executive Officer |
| Itaru Sakaguchi | Group Managing Executive Officer |
| Toshihiko Osada | Group Senior Managing Executive Officer & Director |
| Fumihisa Hirose | Group Managing Executive Officer |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Equipment & Supplies |
| GIC Sub-Industry: | Health Care Equipment |
| Forward PE: | 32.2581 |
|---|---|
| Trailing PE: | 38.4314 |
| Price-to-Book MRQ: | 3.5129 |
| Price-to-Sales TTM: | 0.0295 |
| IPO Date: | |
| Fiscal Year End: | March |
| Full Time Employees: | 0 |